Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.

Saved in:
Bibliographic Details
Title: Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.
Authors: Lammerich, Andreas1 andreas.lammerich@ratiopharm.de, Bias, Peter1, Gertz, Beate1
Source: International Journal of Women's Health. Jul2015, Vol. 7, p707-716. 10p.
Database: Academic Search Ultimate
Description
ISSN:11791411
DOI:10.2147/IJWH.S83418